These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18640334)

  • 21. Impact of early and delayed stroke on in-hospital and long-term mortality after isolated coronary artery bypass grafting.
    Toumpoulis IK; Anagnostopoulos CE; Chamogeorgakis TP; Angouras DC; Kariou MA; Swistel DG; Rokkas CK
    Am J Cardiol; 2008 Aug; 102(4):411-7. PubMed ID: 18678297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early and long-term outcomes in the elderly: comparison between off-pump and on-pump techniques in 1191 patients undergoing coronary artery bypass grafting.
    Li Y; Zheng Z; Hu S
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):657-64. PubMed ID: 18805269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting.
    Mehta RH; Honeycutt E; Shaw LK; Milano CA; Smith PK; Harrington RA; Sketch MH
    Am J Cardiol; 2007 Nov; 100(10):1538-42. PubMed ID: 17996515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
    Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
    Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
    Royston D; Levy JH; Fitch J; Dietrich W; Body SC; Murkin JM; Spiess BD; Nadel A
    Anesth Analg; 2006 Nov; 103(5):1082-8. PubMed ID: 17056936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect on long-term survival of erythrocyte transfusion given for cardiac valve operations.
    Engoren M; Habib RH; Hadaway J; Zacharias A; Schwann TA; Riordan CJ; Durham SJ; Shah A
    Ann Thorac Surg; 2009 Jul; 88(1):95-100, 100.e1-3. PubMed ID: 19559202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
    Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
    Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.
    Kuduvalli M; Oo AY; Newall N; Grayson AD; Jackson M; Desmond MJ; Fabri BM; Rashid A
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):592-8. PubMed ID: 15784356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
    Dietrich W; Busley R; Boulesteix AL
    Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality.
    Yap CH; Sposato L; Akowuah E; Theodore S; Dinh DT; Shardey GC; Skillington PD; Tatoulis J; Yii M; Smith JA; Mohajeri M; Pick A; Seevanayagam S; Reid CM
    Ann Thorac Surg; 2009 May; 87(5):1386-91. PubMed ID: 19379870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short- and midterm outcomes of coronary artery bypass surgery performed by surgeons in training.
    Yap CH; Andrianopoulos N; Dinh TD; Billah B; Rosalion A; Smith JA; Shardey GC; Skillington PD; Tatoulis J; Mohajeri M; Yii M; Reid CM
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1088-92. PubMed ID: 19379972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and early and late outcomes of dialysis-dependent patients in contemporary cardiac surgery.
    Filsoufi F; Rahmanian PB; Castillo JG; Silvay G; Carpentier A; Adams DH
    J Cardiothorac Vasc Anesth; 2008 Aug; 22(4):522-9. PubMed ID: 18662625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Routine use of bilateral skeletonized internal thoracic artery grafting: long-term results.
    Pevni D; Uretzky G; Mohr A; Braunstein R; Kramer A; Paz Y; Shapira I; Mohr R
    Circulation; 2008 Aug; 118(7):705-12. PubMed ID: 18663087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aprotinin and renal dysfunction after pediatric cardiac surgery.
    Székely A; Sápi E; Breuer T; Kertai MD; Bodor G; Vargha P; Szatmári A
    Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies.
    Gagne JJ; Griesdale DE; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):259-68. PubMed ID: 19185048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical volume and outcomes of off-pump coronary artery bypass graft surgery: Does it matter?
    Konety SH; Rosenthal GE; Vaughan-Sarrazin MS
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1116-23.e1. PubMed ID: 19379976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.